Larbig M - Search Results

1

Efficacy and Safety of Garadacimab in Combination with Standard of Care Treatment in Patients with Severe COVID-19.

Papi A, Stapleton RD, Shore PM, Bica MA, Chen Y, Larbig M, Welte T. Papi A, et al. Among authors: larbig m. Lung. 2023 Apr;201(2):159-170. doi: 10.1007/s00408-023-00615-9. Epub 2023 Mar 31. Lung. 2023. PMID: 37000214 Free PMC article. Clinical Trial.

2

One-year follow up of asthmatic patients newly initiated on treatment with medium- or high-dose inhaled corticosteroid-long-acting β₂-agonist in UK primary care settings.

Buhl R, Heaney LG, Loefroth E, Larbig M, Kostikas K, Conti V, Cao H. Buhl R, et al. Among authors: larbig m. Respir Med. 2020 Feb;162:105859. doi: 10.1016/j.rmed.2019.105859. Epub 2019 Dec 30. Respir Med. 2020. PMID: 31916534 Free article.

3

Capturing Exacerbations of Chronic Obstructive Pulmonary Disease with EXACT. A Subanalysis of FLAME.

Frent SM, Chapman KR, Larbig M, Mackay A, Fogel R, Gutzwiller FS, Shen S, Patalano F, Banerji D, Kostikas K, Wedzicha JA. Frent SM, et al. Among authors: larbig m. Am J Respir Crit Care Med. 2019 Jan 1;199(1):43-51. doi: 10.1164/rccm.201801-0038OC. Am J Respir Crit Care Med. 2019. PMID: 30019939 Free PMC article. Clinical Trial.

4

Indacaterol/glycopyrronium versus salmeterol/fluticasone in the prevention of clinically important deterioration in COPD: results from the FLAME study.

Anzueto AR, Kostikas K, Mezzi K, Shen S, Larbig M, Patalano F, Fogel R, Banerji D, Wedzicha JA. Anzueto AR, et al. Among authors: larbig m. Respir Res. 2018 Jun 20;19(1):121. doi: 10.1186/s12931-018-0830-z. Respir Res. 2018. PMID: 29925383 Free PMC article. Clinical Trial.

5

Long-Term Triple Therapy De-escalation to Indacaterol/Glycopyrronium in Patients with Chronic Obstructive Pulmonary Disease (SUNSET): A Randomized, Double-Blind, Triple-Dummy Clinical Trial.

Chapman KR, Hurst JR, Frent SM, Larbig M, Fogel R, Guerin T, Banerji D, Patalano F, Goyal P, Pfister P, Kostikas K, Wedzicha JA. Chapman KR, et al. Among authors: larbig m. Am J Respir Crit Care Med. 2018 Aug 1;198(3):329-339. doi: 10.1164/rccm.201803-0405OC. Am J Respir Crit Care Med. 2018. PMID: 29779416 Free article. Clinical Trial.

6

Pharmacokinetics, Safety, and Tolerability of Fevipiprant (QAW039), a Novel CRTh2 Receptor Antagonist: Results From 2 Randomized, Phase 1, Placebo-Controlled Studies in Healthy Volunteers.

Erpenbeck VJ, Vets E, Gheyle L, Osuntokun W, Larbig M, Neelakantham S, Sandham D, Dubois G, Elbast W, Goldsmith P, Weiss M. Erpenbeck VJ, et al. Among authors: larbig m. Clin Pharmacol Drug Dev. 2016 Jul;5(4):306-13. doi: 10.1002/cpdd.244. Epub 2016 Mar 28. Clin Pharmacol Drug Dev. 2016. PMID: 27310331 Free PMC article. Clinical Trial.

7

Corridors restore animal-mediated pollination in fragmented tropical forest landscapes.

Kormann U, Scherber C, Tscharntke T, Klein N, Larbig M, Valente JJ, Hadley AS, Betts MG. Kormann U, et al. Among authors: larbig m. Proc Biol Sci. 2016 Jan 27;283(1823):20152347. doi: 10.1098/rspb.2015.2347. Proc Biol Sci. 2016. PMID: 26817765 Free PMC article.

8

The dipeptidyl peptidase-4 inhibitor linagliptin lowers postprandial glucose and improves measures of β-cell function in type 2 diabetes.

Heise T, Larbig M, Patel S, Seck T, Hehnke U, Woerle HJ, Dugi K. Heise T, et al. Among authors: larbig m. Diabetes Obes Metab. 2014 Oct;16(10):1036-9. doi: 10.1111/dom.12312. Epub 2014 Jun 9. Diabetes Obes Metab. 2014. PMID: 24821586

9

In type 2 diabetes patients, insulin glargine is associated with lower postprandial release of intact proinsulin compared with sulfonylurea treatment.

Pscherer S, Larbig M, von Stritsky B, Pfützner A, Forst T. Pscherer S, et al. Among authors: larbig m. J Diabetes Sci Technol. 2012 May 1;6(3):634-40. doi: 10.1177/193229681200600318. J Diabetes Sci Technol. 2012. PMID: 22768894 Free PMC article.

10

Adding insulin glargine vs. NPH insulin to metformin results in a more efficient postprandial beta-cell protection in individuals with type 2 diabetes.

Forst T, Larbig M, Hohberg C, Forst S, Diessel S, Borchert M, Roth W, Pfützner A. Forst T, et al. Among authors: larbig m. Diabetes Obes Metab. 2010 May;12(5):437-41. doi: 10.1111/j.1463-1326.2010.01209.x. Diabetes Obes Metab. 2010. PMID: 20415692 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters